Keywords: Biogen Idec, New patent, Recfidera, BG-12, Fresenius Kabi, Parenteral Drugs India, Goa Formulations, M&D

Briefs: Biogen Idec gets new Tecfidera patent; Fresenius Kabi to buy Indian facility

Article | 20 March 2013

Print This

US biotech firm Biogen Idec (Nasdaq: BIIB) yesterday announced that the US Patent and Trademark Office (USPTO) has granted US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in